Ergoteles LLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 130 filers reported holding IMMUNITYBIO INC in Q3 2022. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q2 2022$503,000
+379.0%
135,300
+683.7%
0.02%
+275.0%
Q4 2021$105,000
-77.0%
17,264
-10.1%
0.00%
-71.4%
Q1 2021$456,00019,2000.01%
Other shareholders
IMMUNITYBIO INC shareholders Q3 2022
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 251,556$1,387,0001.70%
ORACLE INVESTMENT MANAGEMENT INC 315,322$1,567,0000.89%
HARBOURVEST PARTNERS LLC 335,709$1,668,0000.54%
ALLEN HOLDING INC /NY 687,571$3,417,0000.54%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$479,0000.21%
SHEETS SMITH WEALTH MANAGEMENT 207,926$1,033,0000.17%
Clearwater Capital Advisors, LLC 185,911$924,0000.13%
WEALTH EFFECTS LLC 28,500$142,0000.09%
Virtus ETF Advisers LLC 35,048$174,0000.07%
Vident Investment Advisory, LLC 195,127$969,0000.03%
View complete list of IMMUNITYBIO INC shareholders